Get started
Applied Therapeutics, Inc.Applied Therapeutics, Inc.Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

APLT chart


Full chart

APLT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪47.14 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.7967 USD
Net income (FY)
‪−105.62 M‬ USD
Revenue (FY)
‪455.00 K‬ USD
Shares float
‪111.03 M‬
Beta (1Y)
0.94

Employees


Employees (FY)
35
Change (1Y)
+10 +40.00%
Revenue / Employee (1Y)
‪13.00 K‬ USD
Net income / Employee (1Y)
‪−3.02 M‬ USD

About Applied Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Leslie David Funtleyder
Website
appliedtherapeutics.com
Headquarters
New York
Founded
2016
FIGI
BBG000DD0489
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

APLT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as APLT.

Frequently Asked Questions


The current price of APLT is 0.3326 USD — it has increased by 9.61% in the past 24 hours. Watch Applied Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Applied Therapeutics, Inc. stocks are traded under the ticker APLT.
APLT stock has risen by 3.26% compared to the previous week, the month change is a −39.45% fall, over the last year Applied Therapeutics, Inc. has showed a −92.95% decrease.
We've gathered analysts' opinions on Applied Therapeutics, Inc. future price: according to them, APLT price has a max estimate of 5.00 USD and a min estimate of 1.50 USD. Watch APLT chart and read a more detailed Applied Therapeutics, Inc. stock forecast: see what analysts think of Applied Therapeutics, Inc. and suggest that you do with its stocks.
APLT reached its all-time high on Feb 4, 2020 with the price of 57.3900 USD, and its all-time low was 0.2950 USD and was reached on Apr 16, 2025. View more price dynamics on APLT chart.
See other stocks reaching their highest and lowest prices.
APLT stock is 14.19% volatile and has beta coefficient of 0.94. Track Applied Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Applied Therapeutics, Inc. there?
Today Applied Therapeutics, Inc. has the market capitalization of ‪47.09 M‬, it has increased by 3.89% over the last week.
Yes, you can track Applied Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Applied Therapeutics, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
APLT earnings for the last quarter are 0.52 USD per share, whereas the estimation was −0.18 USD resulting in a 384.17% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about Applied Therapeutics, Inc. earnings.
Applied Therapeutics, Inc. revenue for the last quarter amounts to ‪−1.00 K‬ USD, despite the estimated figure of ‪614.00 K‬ USD. In the next quarter, revenue is expected to reach ‪4.38 M‬ USD.
APLT net income for the last quarter is ‪44.01 M‬ USD, while the quarter before that showed ‪−68.59 M‬ USD of net income which accounts for 164.16% change. Track more Applied Therapeutics, Inc. financial stats to get the full picture.
No, APLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 35 employees. See our rating of the largest employees — is Applied Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Applied Therapeutics, Inc. EBITDA is ‪−103.87 M‬ USD, and current EBITDA margin is ‪−22.83 K‬%. See more stats in Applied Therapeutics, Inc. financial statements.
Like other stocks, APLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Applied Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Applied Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Applied Therapeutics, Inc. stock shows the sell signal. See more of Applied Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.